Treatment of patients with keratoconjunctivitis sicca with Optive™: results of a multicenter, open-label observational study in Germany

Thomas Kaercher1, Patricia Buchholz2, Friedemann Kimmich31Augenarztpraxis, Heidelberg, Germany; 2Allergan Europe, Ettlingen, Germany; 3Eyecons, Pfinztal, GermanyObjective: To evaluate the efficacy and tolerability of OptiveTM, a new dry eye product containing sodium carboxymethylcellulose (0.5%) and...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Thomas Kaercher, Patricia Buchholz, Friedemann Kimmich
Format: article
Langue:EN
Publié: Dove Medical Press 2008
Sujets:
Accès en ligne:https://doaj.org/article/63120919cba7403bafb0e8d7c707075d
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!